PROTAGENIC THERAPEUTICS PTIX

$0.80 +33.52% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 4 2026-08-20 View →
8-K 8-K 2026-08-20 View →
4 4 2026-08-20 View →
10-Q 10-Q 2026-08-19 View →
10-K 10-K 2026-08-14 View →
4 4 2026-08-12 View →
4 4 2026-08-10 View →
4 4 2026-08-06 View →
4 4 2026-08-03 View →
8-K 8-K 2026-04-07 View →
10-Q 10-Q 2026-03-09 View →
8-K 8-K 2026-03-03 View →
8-K 8-K 2026-02-24 View →
8-K 8-K 2026-01-05 View →
DEF 14A DEF 14A 2025-12-05 View →
10-Q 10-Q 2025-11-26 View →
8-K 8-K 2025-11-26 View →
8-K 8-K 2025-11-05 View →
8-K 8-K 2025-10-31 View →
424B5 424B5 2025-10-24 View →
8-K 8-K 2025-08-22 View →
8-K 8-K 2025-08-13 View →
8-K 8-K 2025-07-30 View →
8-K 8-K 2025-07-24 View →
8-K 8-K 2025-06-27 View →
8-K 8-K 2025-05-21 View →
8-K 8-K 2025-05-20 View →
8-K 8-K 2025-05-19 View →
10-Q 10-Q 2025-05-13 View →
8-K 8-K 2025-05-05 View →
8-K 8-K 2025-04-29 View →
8-K Current report (material event) 2025-04-18 View →
10-K Annual report 2025-03-31 View →
DEF 14A Proxy statement 2025-03-10 View →
8-K Current report (material event) 2025-02-24 View →
8-K Current report (material event) 2025-02-24 View →
8-K Current report (material event) 2025-01-29 View →
8-K Current report (material event) 2025-01-16 View →
8-K Current report (material event) 2025-01-10 View →
424B5 Prospectus supplement 2025-01-10 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.80
Market Cap
52-Week Range
$0.13 $6.20
Average Volume
18K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.